EverSource Wealth Advisors’s Tango Therapeutics TNGX Stock Holding History

EverSource Wealth Advisors’s Portfolio TNGX Stock Details TNGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$44.8K	Sell	1,432 -24,594	-94%	-$608K	﹤0.01%	1849
2026 Q1	$544K	Buy	26,026 +380	+1%	+$5.29K	0.02%	569
2025 Q4	$227K	Sell	25,646 -1,007	-4%	-$8.68K	0.01%	886
2025 Q3	$224K	Buy	26,653 +22	+0.1%	+$149	0.01%	849
2025 Q2	$136K	Buy	26,631 +26,605	+102,327%	+$65.8K	0.01%	1043
2025 Q1	$36	Buy	+26	New	+$64	﹤0.01%	3931

Other funds holding TNGX

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

DACS

Dymon Asia Capital (Singapore) Singapore $2.39B AUM 150.5% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

Caprock Group Boise, Idaho $5.22B AUM 42.47% 1-Year Est. Return

EverSource Wealth Advisors's TNGX Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Tango Therapeutics (TNGX) stake by 94% in Q2 2026, selling an estimated $608K and leaving 1,432 shares worth $44.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1849.

EverSource Wealth Advisors first reported a position in TNGX in Q1 2025 and has held it in 6 quarters since. The position peaked at $544K in Q1 2026. 24 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

EverSource Wealth Advisors held 1,432 shares of Tango Therapeutics worth $44.8K as of Q2 2026.
EverSource Wealth Advisors sold 24,594 Tango Therapeutics shares in Q2 2026, an estimated $608K.
Tango Therapeutics made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #1849 holding.
EverSource Wealth Advisors first reported a position in Tango Therapeutics in Q1 2025 and has held it in 6 quarters since.
EverSource Wealth Advisors's Tango Therapeutics position peaked at $544K in Q1 2026.
24 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.